(ITB) iShares U.S. Home - Ratings and Ratios
Homebuilders, Suppliers, Materials, Real Estate
| Risk via 10d forecast | |
|---|---|
| Volatility | 28.7% |
| Value at Risk 5%th | 45.8% |
| Relative Tail Risk | -3.09% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.71 |
| Alpha | -30.72 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.296 |
| Beta | 0.731 |
| Beta Downside | 0.441 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.35% |
| Mean DD | 10.05% |
| Median DD | 7.25% |
Description: ITB iShares U.S. Home November 09, 2025
The iShares U.S. Home Construction ETF (ITB) tracks a proprietary index that captures the performance of U.S. home-building equities. By regulation, the fund must allocate at least 80% of its capital to the index’s constituent stocks, while the remaining 20% may be placed in futures, options, swaps, cash, or cash equivalents, rendering the vehicle non-diversified and therefore more sensitive to sector-specific shocks.
Key drivers of the underlying sector include residential-building permits and housing-starts data, which have risen ~4% YoY in Q3 2024, and the NAHB/Wells Fargo Housing Market Index, currently at 62, indicating modest builder confidence. Mortgage-rate movements remain critical: a 0.25 % increase in the 30-year Treasury yield typically depresses new-home starts by roughly 0.5 % in the subsequent month, based on historical elasticity estimates.
Recent macro-level pressures-tight labor markets, elevated material-cost inflation, and supply-chain bottlenecks-have compressed profit margins for major builders, with average EBIT margins falling from 12.3 % in early 2023 to 10.8 % in the latest quarter. Conversely, the sector benefits from a lagging inventory-to-sales ratio (≈1.4 months), suggesting potential upside if demand remains resilient.
For a deeper, data-driven look at ITB’s risk-adjusted performance and how it fits within a broader construction-sector allocation, consider reviewing the analytics on ValueRay.
ITB ETF Overview
| Market Cap in USD | 2,540m |
| Category | Consumer Cyclical |
| TER | 0.40% |
| IPO / Inception | 2006-05-01 |
| Return 12m vs S&P 500 | -28.4% |
| Analyst Rating | - |
ITB Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 1.66% |
| Yield on Cost 5y | 2.82% |
| Yield CAGR 5y | 16.37% |
| Payout Consistency | 91.4% |
| Payout Ratio | - |
ITB Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 17.29% |
| CAGR/Max DD Calmar Ratio | 0.52 |
| CAGR/Mean DD Pain Ratio | 1.72 |
| Current Volume | 1294.8k |
| Average Volume | 2000.9k |
What is the price of ITB shares?
Over the past week, the price has changed by -5.64%, over one month by -9.68%, over three months by -15.43% and over the past year by -18.68%.
Is ITB a buy, sell or hold?
What are the forecasts/targets for the ITB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 98.3 | 4.8% |
ITB Fundamental Data Overview November 11, 2025
Beta = 1.72
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.54b USD (2.54b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.54b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.54b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.71% (E(2.54b)/V(2.54b) * Re(8.71%) + (debt-free company))
Discount Rate = 8.71% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for ITB ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle